Therapeutic Efficacy of G207, a Conditionally Replicating Herpes Simplex Virus Type 1 Mutant, for Gallbladder Carcinoma in Immunocompetent Hamsters
Open Access
- 1 April 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (4), 431-437
- https://doi.org/10.1006/mthe.2001.0303
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Viral Shedding and Biodistribution of G207, a MuItimutated, Conditionally Replicating Herpes Simplex Virus Type 1, after Intracerebral Inoculation in AotusMolecular Therapy, 2000
- Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialGene Therapy, 2000
- Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapyCancer Gene Therapy, 2000
- Corticosteroid Administration Does Not Affect Viral Oncolytic Activity, but Inhibits Antitumor Immunity in ReplicationCompetent Herpes Simplex Virus Tumor TherapyHuman Gene Therapy, 1999
- Systemic Antitumor Immunity in Experimental Brain Tumor Therapy Using a Multimutated, Replication-Competent Herpes Simplex VirusHuman Gene Therapy, 1999
- Local and Systemic Therapy of Human Prostate Adenocarcinoma with the Conditionally Replicating Herpes Simplex Virus Vector G207Human Gene Therapy, 1999
- Selective Infection and Cytolysis of Human Head and Neck Squamous Cell Carcinoma with Sparing of Normal Mucosa by a Cytotoxic Herpes Simplex Virus Type 1 (G207)Human Gene Therapy, 1999
- Herpes Simplex Virus as an in Situ Cancer Vaccine for the Induction of Specific Anti-Tumor ImmunityHuman Gene Therapy, 1999
- Treatment of Human Breast Cancer in a Brain Metastatic Model by G207, a Replication-Competent Multimutated Herpes Simplex Virus 1Human Gene Therapy, 1998
- ScienceScopeScience, 1995